Wireless image transfer across opaque cornea: A novel approach to visual rehabilitation [0.03%]
一种视觉康复的新方法：角膜不透明条件下的无线图像传输技术
Radhika Natarajan
Radhika Natarajan
Fight retinoblastoma India: A decade of collective action, collaboration, and patient-centered care [0.03%]
印度联合行动十年：视网膜母细胞瘤的防治与以患者为中心的治疗模式
Poonam Bagai,Santosh G Honavar,Amita Mahajan et al.
Poonam Bagai et al.
Needle-assisted iris-claw lens implantation: A novel, simplified technique for aphakia without capsular support [0.03%]
针辅助虹膜夹持型人工晶状体植入治疗无囊袋支撑的无晶状体眼：一种新型简单技术
Parth Palan,Muralidhar Ramappa
Parth Palan
We introduce a novel, simplified surgical technique for iris-claw intraocular lens implantation in aphakia cases without adequate capsular support. The Needle Assisted Iris-claw Lens (NAIL) technique utilizes a 10-0 prolene straight needle ...
Comparative experience of phaco-I and kitaro eye models among ophthalmology trainees in Malaysia: A preliminary study [0.03%]
马来西亚眼科住院医师在Phaco-I和Kitaro眼部模型上的对比经验：一项初步研究
Ming Yean Ong,Chenshen Lam,Pei Rong Chiun et al.
Ming Yean Ong et al.
Purpose: To compare the user experience of Phaco-I and Kitaro among Malaysian ophthalmology trainees during phacoemulsification simulation. Secondary objectives included the preliminary validation of a questionnaire desig...
Comparative Study
Indian journal of ophthalmology. 2026 May 1;74(Suppl 1):S52-S58. DOI:10.4103/IJO.IJO_2721_25 2026
Intrauterine stroke from a sword on the face - A rare diagnosis and its long-term sequelae [0.03%]
面部中剑导致的宫内脑卒中的罕见病例及其长期后遗症
Josh Kumar,Sahil Agrawal,Neelam Pushker
Josh Kumar
Anti-vascular endothelial growth factor therapy for posterior segment diseases: Progress, challenges, and the road ahead [0.03%]
抗血管内皮生长因子治疗后段眼病：进展、挑战与未来方向
Chitaranjan Mishra,Nabatika Mohanty,Somy Purohit et al.
Chitaranjan Mishra et al.
The emergence of anti-vascular endothelial growth factor (anti-VEGF) therapy has marked a paradigm shift in the treatment of retinal and choroidal vascular diseases. Following the identification of VEGF as a central mediator of pathological...
Current role of aflibercept in retinopathy of prematurity - A review [0.03%]
阿柏西普在早产儿视网膜病变治疗中的作用初探-综述文章
Devesh Kumawat,Nawazish Shaikh,Parijat Chandra
Devesh Kumawat
The introduction of intravitreal anti-vascular endothelial growth factor (VEGF) therapy has transformed the management of severe retinopathy of prematurity (ROP) in the zone I/zone II posterior region and aggressive ROP by enabling rapid di...
Anti-vascular endothelial growth factors in retinal and choroidal diseases - Present landscape [0.03%]
抗血管内皮生长因子治疗视网膜和脉络膜疾病之现况与展望
Naresh B Kannan,Muthukrishnan Vallinayagam,Konduru Rishitha et al.
Naresh B Kannan et al.
Anti-vascular endothelial growth factors (anti-VEGFs) are agents that block the activity of specific bio-active molecules responsible for the growth of abnormal blood vessels. The advent of anti-VEGF therapy has revolutionized the treatment...
Non-intravitreal anti-vascular endothelial growth factor delivery for ocular neovascular diseases: Current status and future directions [0.03%]
非静脉内血管内皮生长因子传递治疗眼新生血管性疾病：现状与未来方向
Shrinivas M Joshi,Giriraj Vibhute,Shailesh M Rao et al.
Shrinivas M Joshi et al.
Intravitreal anti-vascular endothelial growth factor (VEGF) therapy has fundamentally transformed the management of retinal and choroidal neovascular diseases. Despite its proven efficacy, long-term reliance on repeated intravitreal injecti...
The evolving role of artificial intelligence in optimizing treatment and patient selection in diabetic macular edema [0.03%]
人工智能在糖尿病性黄斑水肿治疗和患者选择中的作用的演变
Dhanashree Ratra,Ramachandran Rajalakshmi,M Suchetha et al.
Dhanashree Ratra et al.
Anti-vascular endothelial growth factor (anti-VEGF) therapy is the mainstay of management for diabetic macular edema (DME), but marked variability in response, high injection frequency, and cumulative treatment burden highlight the need for...